Delivery Order SPE2DB22D2007-SPE2DB25FJ2WX
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug Mounjaro in a 7.5 mg/0.5 ml pen, with a ceiling value of $13,867.71 and a performance period ending on June 4, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $21,606.55 and has an ultimate completion date of January 17, 2025. It is for the procurement of the drug Mounjaro, a 12.5 mg/0.5 mL pen with a 0.5 mL volume. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,462.55 contract is for the supply of the drug Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) and has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,833.16 and a period of performance through May 7, 2025. This contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Mounjaro 5 mg/0.5 ml pen. The award, valued at $3,156.00, is a firm fixed-price contract with an ultimate completion date of August 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of the medication Mounjaro 5 mg/0.5 ml pen in 0.5 ml quantities, with a ceiling value of $3,555.12 and a period of performance through May 15, 2024. This award was not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567529340 - MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,225.77 and a period of performance through March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of May 28, 2025 and a ceiling value of $6,400.32. The contract is not set aside for any small business program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a $3,265.08 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Mounjaro 5 mg/0.5 ml pen (0.5 ml) and has a completion date of May 13, 2025. The contract is not set aside and appears to be part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $4,551.12. The order is for the drug Mounjaro 5 mg/0.5 ml pen 0.5 ml, a treatment likely for diabetes or another medical condition. This order is not set aside and represents open competition. AmerisourceBergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2WXDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro 5 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $10,010.56 and a period of performance through July 10, 2025. This order is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 7/9/25 |